Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, October 28 at 2:00 PM ET

Register Free →

This Solicitation opportunity from Department Of Health And Human Services was posted on June 30, 2026. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

75N98026Q00716

Closed
75N98026Q00716Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

NAICS: 813920
Federal
Biomedical Research Application Evaluation and Support (BRAES)
Solicitation # HT942727RE006
The Biomedical Research Application Evaluation and Support (BRAES) contract is a performance-based, non-commercial Multiple Award Indefinite Delivery Indefinite Quantity (MA-IDIQ) solicitation issued by the Defense Health Agency for the Congressionally Directed Medical Research Programs. With a ceiling cost of 137 million dollars and an estimated period of performance from January 2027 to January 2032, the contract supports the evaluation of biomedical research applications. The scope is divided into four primary areas: funding opportunity announcement set-up, oversight of application receipt and processing, application compliance review, and scientific merit peer review. While the first three tasks are awarded to a single vendor via the eBRAP task order, the scientific peer review tasks are awarded to multiple vendors through Science Administration and Management (SAM) task orders, which require the operation of a secure, contractor-owned, contractor-operated (COCO) web-based system. The government will utilize a Highest Technically Rated with a Fair and Reasonable Cost/Price approach to select approximately three awardees. Evaluation factors include technical approach, management approach, past performance, and small business participation, with cost and price serving as the final check for the highest-rated proposals. Key requirements for offerors include an active SAM registration, a CMMC Level 1 self-assessment, and the submission of a five-volume proposal by December 2, 2026. Contract administration involves a mix of Cost Plus Fixed Fee and Firm Fixed Price arrangements, with invoicing processed through the Wide Area Workflow system. Performance is monitored via Quality Assurance Surveillance Plans using random sampling and 100 percent inspection to determine CPARS ratings based on accuracy and schedule adherence.
Army Medical Resources Acq Activity

POSTED

9 days ago

DEADLINE

in about 1 month

AI Contract Overview

Show more

The contract under solicitation number 75N98026Q00716, issued by the National Cancer Institute of the National Institutes of Health, seeks to advance corrective editing research on splicing factor mutations in Myelodysplastic Syndromes and Chronic Myelomonocytic Leukemia through a sole source award to Moffitt Cancer Center & Research Institute. This procurement is justified under FAR 6.302-1 due to the unique and irreplaceable combination of clinical expertise, access to a large and rare patient population, and integrated infrastructure for patient-derived xenograft modeling that only Moffitt possesses. The work must be conducted within a single institutional environment to preserve specimen integrity and ensure seamless translational research from clinical evaluation through cellular manipulation and xenograft transplantation, eliminating the need for specimen transport between sites. The contract is a service-based award under NAICS code 813920, with an anticipated award date following the July 9, 2026 submission deadline, and performance will be coordinated from the contracting office in Bethesda, Maryland, though all research activities will be executed at Moffitt’s facility. No pricing details, contract type, period of performance, or payment information are specified, and no formal clause, delivery, packaging, or inspection standards are detailed beyond the overarching requirement that all work meet the specialized scientific and clinical benchmarks essential to MDS and CMML research. Submission of capability statements via email to the designated point of contact is required, with no formal proposal structure, page limits, or mandatory certifications provided, and no small business or socioeconomic set-aside applicability is enforced since this is a sole source acquisition.

General Info

Develop precise gene therapies to correct splicing mutations in blood cancers using CRISPR or next-gen tech for clinical translation.

NAICS

813920 - Professional Organizations

Place of Performance

MD

Set-Aside

NONE

Documents

1

75N98026Q00716 Sole Source Justification for Moffitt Cancer Center

DOCX, Low priorityjustification-and-authorization
Low

AI Contract Breakdown

Uniform Contract Format

Sign up to view the full breakdown with detailed analysis of each section.

Timeline

PhaseClosed
Posted

Solicitation

Response Deadline

Deadline has passed

Submission Closed

Find active opportunities like this

Start your free trial to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

Show more
AgencyDepartment Of Health And Human Services → National Institutes Of Health Olao
Contacts1 person available
OfficeBETHESDA, MD, 20892, USA
Office AddressBETHESDA, MD, 20892, USA

Full Description

Show more
NCI - Corrective Editing of Splicing Factor Mutant Myelodysplastic Syndromes and Chronic Myelomonocytic Leukemia

More opportunities from Department Of Health And Human Services → National Institutes Of Health Olao

Same awarding agency

NAICS: 334516
New
Federal
Baxter/Hill-Rom Helux Pro Surgical Light System
Solicitation # 75N98027Q00038PCA-NIA-11810
The National Institutes of Health, through the National Institute on Aging, is seeking a firm fixed-price contract for the procurement, delivery, and turnkey installation of a Baxter/Hill-Rom Helux Pro Surgical Light system. This acquisition is intended for the NIA Clinical Research Unit in Baltimore, Maryland, to support invasive outpatient biopsy procedures and maintain clinical continuity. The scope of work includes the de-installation of obsolete hardware and the installation of a medical-grade LED lighthead with a ceiling-mounted single-arm suspension. Technical requirements specify a Color Rendering Index of 95 or higher, deep-red rendering of 90 or higher, and support for DICOM imaging standards via a 55-inch wall-mounted 4K/UHD monitor. This is a combined synopsis and solicitation conducted under FAR Part 12.6 for commercial items, and it is not expected to exceed the simplified acquisition threshold. The contract is open to full and open competition and is not set aside for small businesses, falling under NAICS code 334516. Award will be based on the best value, considering price and other factors such as warranty, lifecycle cost, and maintenance availability. A minimum one-year OEM warranty is required, supplemented by multi-year agreements for the lighthead and integrated system. Interested offerors must be registered in the System for Award Management and submit their proposals by December 8, 2026, at 2:00 PM EST.
Analytical Laboratory Instrument Manufacturing

POSTED

about 23 hours ago

DEADLINE

in about 1 month
View Details
NAICS: 621111
New
Federal
Rheumatologist/Oral Surgeon Johns Hopkins University FY27
Solicitation # NIH-NOI-PCA-NIDCR-11424
The National Institute of Dental and Craniofacial Research (NIDCR), under the National Institutes of Health (NIH) and Department of Health and Human Services (HHS), has issued a Notice of Intent to Sole Source for rheumatologist services. The government intends to award a sole source purchase order to Johns Hopkins University under FAR 13.501(a) and FAR 6.302-1, citing them as the only source capable of providing the specialized expertise required for the NIDCR Salivary Gland Disorders research program. The base period of performance is scheduled from November 28, 2026, through November 27, 2027, with services performed in Bethesda, Maryland. The requirement is for a part-time rheumatologist to provide 832 annual hours of clinical, research, and training support for the Dental Clinical Resource Core and the Salivary Gland Disorders research team. Key responsibilities include the clinical management of patients with rheumatologic conditions associated with salivary gland pathology, subject screening and enrollment for research protocols, and participation in academic publications and presentations. The contractor must provide support to the NIDCR Dental Clinic two days per week, split between on-site and off-site work. Minimum qualifications include a medical degree, an active U.S. medical license, and a strong publication record in Sjogren’s syndrome and related oral manifestations. While this is a sole source intent, interested parties may submit capability statements to the designated points of contact by November 6, 2026.
Offices of Physicians (except Mental Health Specialists)

POSTED

about 23 hours ago

DEADLINE

in 9 days
View Details

Find Active Opportunities Like This

Get AI-powered intelligence on the opportunities still open

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS